Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual MeetingBusiness Wire • 04/23/25
Pfizer Earnings Preview: Pharma May Plumb New Depths After Obesity Drug DebacleSeeking Alpha • 04/23/25
S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer BuysThe Motley Fool • 04/23/25
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/22/25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (April 2025)24/7 Wall Street • 04/21/25
If You Like Schwab's SCHD, You Can't Miss These Stocks With Even Higher Yields24/7 Wall Street • 04/18/25
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?The Motley Fool • 04/18/25
3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold ForeverThe Motley Fool • 04/18/25
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59Zacks Investment Research • 04/17/25
Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right NowThe Motley Fool • 04/17/25
ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of DiseaseBusiness Wire • 04/16/25